Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2015 / Article
Special Issue

Oxidative Stress-Mediated Reperfusion Injury 2014

View this Special Issue

Research Article | Open Access

Volume 2015 |Article ID 364020 | https://doi.org/10.1155/2015/364020

Wei Xuan, Quanjun Zhou, Shanglong Yao, Qingzhu Deng, Tingting Wang, Qingping Wu, "Mechanical Ventilation Induces an Inflammatory Response in Preinjured Lungs in Late Phase of Sepsis", Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 364020, 8 pages, 2015. https://doi.org/10.1155/2015/364020

Mechanical Ventilation Induces an Inflammatory Response in Preinjured Lungs in Late Phase of Sepsis

Academic Editor: Zhengyuan Xia
Received21 Jul 2014
Revised09 Oct 2014
Accepted16 Oct 2014
Published16 Jun 2015


Mechanical ventilation (MV) may amplify the lung-specific inflammatory response in preinjured lungs by elevating cytokine release and augmenting damage to the alveolar integrity. In this study, we test the hypothesis that MV exerts different negative impacts on inflammatory response at different time points of postlung injury. Basic lung injury was induced by cecal ligation and puncture (CLP) surgery in rats. Physiological indexes including blood gases were monitored during MV and samples were assessed following each experiment. Low (tidal volume) MV caused a slight increase in cytokine release and tissue damage at day 1 and day 4 after sepsis induced lung injury, while cytokine release from the lungs in the two moderately ventilated groups was amplified. Interestingly, in the two groups where rats received low MV, we found that infiltration of inflammatory cells was only profound at day 4 after CLP. Marked elevation of protein leakage indicated a compromise in alveolar integrity in rats that received moderate MV at day 4 following CLP, correlating with architectural damage to the alveoli. Our study indicates that preinjured lungs are more sensitive to mechanical MV at later phases of sepsis, and this situation may be a result of differing immune status.

1. Introduction

Patients suffering from acute lung injury (ALI) or acute aspiratory distress syndrome (ARDS) are likely to receive mechanical ventilation (MV) treatment as a therapeutic intervention [1]. Although MV is necessary and life-saving, it may cause lung injury or exacerbate preexisting lung injury, a condition known as ventilator-associated lung injury (VILI) [2, 3]. Curative strategy of MV can cause VILI via the induction of oxidant stress and neutrophil infiltration in a rat model [4].

Sepsis is a critical state of inflammation with high morbidity and mortality rates in the intensive care unit (ICU) [5]. Certain factors, such as overgeneration of reactive oxygen species (ROS), play important roles between sepsis and VILI. Both in vivo and in vitro studies have demonstrated that oxidative stress, plus dysfunction of antioxidant system, leads to the onset or deterioration of ALI after sepsis and VILI [6, 7]. On the other hand, sepsis can overwhelm the body resulting in immune suppression, leaving patients more susceptible to secondary infections due to an inability to mount an effective inflammatory response [810]. The generation of reactive oxygen species by immune cells can be changed depending on different phase of sepsis [11], in which persistence indicates a poor result and may affect the outcome of VILI due to the modulation of ROS elimination. Previous studies have shown that MV had a negative impact on preinjured lungs or other organs affected by sepsis [1214].

The purpose of this study was to investigate how MV impacts upon preinjured lung function at different time points after sepsis induction. We used a clinically relevant septic rat model to assess prolonged lung injury. We hypothesized that the negative impacts of MV on preinjured lung at the later phase of sepsis may be more severe than those observed in the early phase. We did not include a high (more than 12 mL/kg) of MV in our current study due to the fact that it was not clinically relevant and this method results in -induced serious lung injury in patients and a range of animal models [1517]. To evaluate the effects of MV on preexisting lung injury, we examined the physiological response, lung injury, inflammatory cell accumulation and infiltration, and cytokine release using septic rat model.

2. Materials and Methods

2.1. Animals and Experimental Sepsis

We used pathogen-free male Sprague-Dawley rats (weighing 250–300 g). All rats in the sepsis groups received cecal ligation and puncture (CLP) surgery. In brief, rats were fasted 16 h before surgery and then anesthetized by an injection of 1 mL of 2% pentobarbital in the peritoneal cavity. Under sterile conditions, a 2 cm incision was made on the midline of the abdomen, before exposing the cecum. The cecum was ligated one-third along its distal position and punctured twice with a 16-gauge needle. This operation caused ALI and had a 95% survival rate in our preliminary study (data not shown). The cecum was returned to the peritoneal cavity and the incision was closed in two layers by suture. All the animals received subcutaneous application of 10 mL/kg sterile saline for fluid resuscitation. The experimental protocol was approved by the Animal Care and Scientific Committee of Tongji Medical College, Huazhong University of Science and Technology.

2.2. Mechanical Ventilation (MV) Protocol

All rats were randomly allocated into seven groups as follows (four MV groups were ventilated for 4 hours with room air): control group: control rats (); group CLP1day: septic rats were sacrificed at day 1 after CLP without MV (); group CLP1day + LMV: septic rats received MV at day 1 after CLP, low (6 mL/kg), 4 cm H2O ZEEP (); group CLP1day + MMV: septic rats received MV at day 1 after CLP, moderate (12 mL/kg), 2 cm H2O ZEEP (); group CLP4day: septic rats were sacrificed at day 4 after CLP without MV (); group CLP4day + LMV: septic rats received MV at day 4 after CLP, low (6 mL/kg), 4 cm H2O ZEEP (); group CLP4day + MMV: septic rats received MV at day 4 after CLP, moderate (12 mL/kg), 2 cm H2O ZEEP (). All rats were anesthetized by intraperitoneal injection of 2% pentobarbital (1 mL) before undergoing tracheotomy and were connected to a small-animal ventilator (Harvard Apparatus, Holliston, MA, USA). Anesthesia was maintained by constant injection of pentobarbital (80 mg/kg/h) and fluids were administered at a rate of 10 mL/kg/h by jugular vein intubation. A catheter was inserted into the left carotid artery for blood pressure measurements and blood gas analysis every two hours. We kept partial pressure of arterial carbon dioxide (CO2) between 35 and 45 mmHg by changing breathing rate. Body temperature was monitored rectally and regulated automatically by a heating pad. All animals were sacrificed by abdominal aorta exsanguination at experiment completion.

2.3. Histology of the Lung

The superior lobe of the right lung was fixed in 10% pH neutral formalin for 24 h, cut into 10 µm sections, and mounted on glass slides. The tissue sections were stained with hematoxylin and eosin (H&E) and examined by light microscopy. The histological alterations were scored in five grades from 0 to 4 depending on the degree of microscopic damage of architectural integrity, inflammatory cell infiltration, interstitial edema, and hemorrhage.

2.4. Cell Counts

Lung lavages were performed with 3 × 2 mL cold sterile PBS; the fluid was centrifuged at 150 ×g at 4°C for 10 min. After centrifugation, the supernatant was collected and frozen at −70°C for further analysis. The cell pellet was resuspended in 0.5 mL cold PBS. Total cell counts of bronchoalveolar lavage fluid (BALF) were determined using a cell counting chamber. Slides of the differential counts were performed using a cytocentrifuge at 150 ×g for 5 min, followed by Wright staining.

2.5. Cytokine Assays

Level of interleukin- (IL-) 6 in the supernatant of BALF was measured by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s protocol. Briefly, samples or standards were pipetted into microplate wells precoated with monoclonal antibody. After washing away unbound substances, an enzyme-linked polyclonal antibody specific for rat IL-6 (BD Biosciences Pharmingen, San Diego, CA, USA) was added to the microplate wells. Following a wash to remove any unbound antibody-enzyme reagent, substrate solution was added to the wells. The enzyme reaction yielded a blue product that turned yellow when the phosphoric acid stop solution was added. The intensity of the color was proportionate to the amount of total rat IL-6 bound in the initial step and the sample values were then extrapolated from the standard curve. Total protein levels in BALF were determined by Pierce BCA Protein Assay kit (Thermo Scientific, Rockford, IL, USA) according to the manufacturer’s instructions with bovine serum albumin (BSA) as a standard.

2.6. Statistical Analysis

Data are expressed as mean ± SD (standard deviation). All parameters were analyzed by one-way analysis of variance (ANOVA) with least significant difference (LSD) posttest. The histological injury scores comparisons were made by the nonparametric Mann-Whitney test. values of <0.05 were considered to be statistically significant.

3. Results

Two rats died from cardiovascular collapse: one in group two and one in group 3. Therefore, only 48 rats out of 50 were studied.

3.1. MV Impacts on Physical Signs

There was no statistically significant difference in O2/FiO2 among the four MV groups at the start of ventilation. Furthermore, the oxygen index (OI) was only slightly higher in the two CLP day-four groups (Figure 1(a)). The OI differed over time in all groups with the lowest O2/FiO2 occurring in group CLP1day + LMV, while the highest OI occurred in group CLP4day + MMV.

The initial mean arterial pressure (MAP) was similar and gradually decreased over time in all groups (Figure 1(b)). The lowest blood pressure measurement was observed in group CLP1day + LMV, but this drop was not statistically significant. Heart rate (HR) was steady in the other three MV groups but had a statistically significant rise in group CLP1day + LMV after 2 h MV (Figure 1(c)).

Although there was a trend of lower pH in groups CLP1day + LMV and CLP1day + MMV, the pH values generally matched those in groups CLP4day + LMV and CLP4day + MMV (data not shown).

3.2. Lung Injury

CLP surgery caused moderate structural damage of lung, slight cellular infiltration, and edema at days one and four after operation (Figures 2(a) and 2(d)). We saw more severe accumulation of inflammatory cells in groups CLP1day + LMV and CLP4day + LMV (Figures 2(b) and 2(e)). For moderate MV one day after sepsis, these histological changes were similar to those in two low groups (Figure 2(c)). The impacts of MV were most evident in group CLP4day + MMV, with partial interstitial edema and areas of alveolar hemorrhage (Figure 2(f)), which showed that relatively higher tidal volume MV exerted more negative impact on preinjured lung at day four after CLP compared with day one following CLP.

3.3. Cell Counts

BALF total cell counts are an important indicator of the integrity of lung capillary. From the results, we can see that CLP surgery increased the total cell counts in BALF (Figure 3(a)). There were large increases in groups of CLP4day + LMV and CLP4day + MMV, while in the groups of day one after CLP, only MMV caused a significant increase of total cell counts. Differential analysis revealed similar increases of polymorphonuclear (PMN) cells in BALF except in group CLP1day + LMV (Figures 3(b) and 4). Examination of tissue slides under light microscopy validated these observations. Additionally, MV magnified the inflammatory cells infiltration to a deeper extent at day four after CLP compared with day one after CLP. These data are in accordance with the findings from histological sections.

3.4. Total Protein and IL-6 Levels

BALF total protein level was quantified to identify the status of capillary permeability and IL-6 was selected as a representative inflammatory cytokine. Studies have shown that moderate can augment rabbit lung cytokine release, such as TNF- and IL-8, after the systemic of systemic LPS [18]. IL-6 is regarded as an active factor and an ongoing inflammatory marker of many lung diseases [19]. The synergistic role of IL-6 in pathologic mechanical stretch induced lung endothelial cell injury has also been demonstrated in vitro [20]. As shown in Figure 5, both total protein and IL-6 were significantly higher in group CLP4day + MMV when compared to groups CLP4day and CLP4day + LMV, which indicated that, on the fourth day after initiation of CLP, relatively higher volume of MV severely increases both lung capillary permeability and cytokine release. Furthermore, IL-6 was significantly higher in group CLP1day + MMV compared with groups CLP1day and CLP1day + LMV, while there were no statistically significant differences in total levels of protein observed between these groups (Figure 5). These results suggested that, at the early stage of sepsis (day one after CLP), when compared to low tidal volume, moderate tidal volume of MV changed inflammatory cytokine release but had no effect on lung capillary permeability.

4. Discussion

The aim of this study was to investigate whether MV exerts distinct effects on lungs at different time after lung injury. We hypothesized that MV would induce an inflammatory response following induction of sepsis by CLP surgery and that this response would be amplified over time. According to our findings, no changes could be found in the inflammatory response at one day after sepsis induction by LMV, but both LMV and MMV did show more severe inflammatory cytokine release and lung injury at a later phase of sepsis.

Acute lung injury (ALI) is a common life-threatening condition that often needs the treatment of MV [1]. Nevertheless, MV can amplify the inflammatory response of preinjured lungs or induce massive release of cytokines from healthy lungs [21, 22], a finding that was validated in our current study. In patients with ARDS, higher tidal volume of MV increases mortality [23]. A recent study showed that MV with a low tidal volume (6 mL/kg) reduced the incidence of mechanical associated lung injury in patients without preexisting lung injury [24]. Therefore, it is now a common view among experts that MV with a low tidal volume protects lungs for patients with and without preexisting lung injury. However, no studies have investigated whether preinjured lungs responded differently to MV at different periods of sepsis. We believe that this information will be meaningful for the determination of the proper tidal volume on a case-by-case basis.

Negative synergistic effects of MV at single time points after sepsis have been found and higher tidal volume tends to be more detrimental [16, 25, 26]. We examined whether moderate tidal volume could be more detrimental to preinjured lungs when compared to low tidal volume in two typical phases of sepsis (one day versus four days) in this study. Furthermore, we examined the effects of two settings (low versus moderate tidal volume) of MV on lungs at different days after initiation of lung injury induced by sepsis.

Low MV caused some heart rate fluctuation and insufficient oxygen index in the first day in the CLP group, where early phase of sepsis was used. Moderate tidal volume MV provided better oxygenation and hemodynamic stability. We found that BALF total protein concentrations were not significantly different among the groups except on the fourth day with moderate MV, which caused a significant increase in total protein concentration. This could be explained by the more severe histological alterations observed in the same group, in which the loss of alveolar integrity would cause more protein leakage.

In terms of BALF total cell counts and PMN differential counts, we observed that effects of moderate MV were similar at different days following sepsis. However, low MV attracted more inflammatory cells and induced more PMN differentiation at the fourth day after sepsis. The concentrations of IL-6 were greater in the group receiving moderate MV at the first and fourth day. This trend was more evident in group 7 on the fourth day after CLP.

These results suggest that although there are some differences between low and moderate MV at the first day of sepsis in our model, moderate MV four days after sepsis are more likely to exert a negative impact on inflammatory lungs responses. Furthermore, for rats receiving low MV, only after four days were synergistic effects on total cell and PMN differential counts observed. This consequence may result from diverse functions of immune cells during sepsis. The immune system plays an important role in the host-pathogen relationship, particularly during sepsis, since sepsis can cause immune suppression that affects the response to other infectious threats [27]. Patients suffering from sepsis undergo certain adaptive responses including a phase of immunosuppression [2830], and animals are susceptible to infections in the lung or peripheral blood [31, 32]. This situation may be induced by impaired function of immune cells or dysfunctional cell signaling pathways [10, 33, 34]. Since MV can influence immune cells such as macrophages or alveolar epithelial cells to cause trauma [35, 36], different immune cell states determine different influences of MV. Furthermore, due to the influence of a number of perioperative factors, certain cell functions can be modulated via ROS system [37]. The expression of toll-like receptors (TLRs) is also associated with mechanical induction of lung injury [38, 39]. Previous studies have shown that signal transduction of TLRs can be modulated by sepsis [10]. Taking this into consideration, TLR4 may directly alter the interaction between MV and lungs that were preinjured by sepsis. At the early phase of sepsis, immune cells may not be sensitive to MV due to immunosuppression; thus MV only cause mild inflammatory response.

The function of immune system and ROS generation are variable at a different time point during the process of sepsis [12]. Campos et al. revealed that antioxidant N-acetylcysteine could alleviate ALI after CLP followed by low MV in a rat, and this protective effect was attributed to the decrease of oxidative stress [13]. ROS also has the property to increase TLR expression of alveolar macrophages in a mice hemorrhagic shock model [40]. Based on the interaction between MV and immune cells mentioned above, it is reasonable to link the variation of VILI to the production of ROS that at the later phase of sepsis, the fourth day after CLP. In our current experiment, more severe lung injury can be found after the treatment of MV.

Our results confirm that although lung-protective MV with low is important in minimizing the negative impact of MV on lungs, sometimes it cannot meet all physiological requirements in the septic rat model. It may be beneficial to increase the tidal volume in certain periods after sepsis to improve the oxygenation or stabilize the circulation system, without worrying about the consequent inflammatory response. However, our study suggests that a specific window of time exists at the later phase of sepsis to consider the changes to MV as an intervention.

5. Conclusions

We have found that moderate MV causes a more severe inflammatory response when compared to low MV in preinjured lungs, and this effect is more evident at a later phase (fourth day) of sepsis. Furthermore, low MV causes greater synergistic inflammatory effects at later period of sepsis. It will be important to investigate if the different status of ROS generation of immune cells contributes to these phenomena in future studies.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Wei Xuan and Quanjun Zhou contributed equally to this work.


The study was supported by a grant from the National Natural Science Foundation of China (no. 81370112 and no. 81200609).


  1. M. A. Matthay and R. L. Zemans, “The acute respiratory distress syndrome: pathogenesis and treatment,” Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 147–163, 2011. View at: Publisher Site | Google Scholar
  2. D. Dreyfuss and G. Saumon, “Ventilator-induced lung injury: lessons from experimental studies,” The American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 294–323, 1998. View at: Publisher Site | Google Scholar
  3. J. A. Frank, P. E. Parsons, and M. A. Matthay, “Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies,” Chest, vol. 130, no. 6, pp. 1906–1914, 2006. View at: Publisher Site | Google Scholar
  4. L.-F. Li, C.-T. Yang, C.-C. Huang, Y.-Y. Liu, K.-C. Kao, and H.-C. Lin, “Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B,” Respiratory Research, vol. 12, article 90, 2011. View at: Publisher Site | Google Scholar
  5. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, “The epidemiology of sepsis in the United States from 1979 through 2000,” The New England Journal of Medicine, vol. 348, no. 16, pp. 1546–1554, 2003. View at: Publisher Site | Google Scholar
  6. S. Tasaka, F. Amaya, S. Hashimoto, and A. Ishizaka, “Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome,” Antioxidants and Redox Signaling, vol. 10, no. 4, pp. 739–753, 2008. View at: Publisher Site | Google Scholar
  7. K. E. Chapman, S. E. Sinclair, D. Zhuang, A. Hassid, L. P. Desai, and C. M. Waters, “Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 289, no. 5, pp. L834–L841, 2005. View at: Publisher Site | Google Scholar
  8. J. Wynn, T. T. Cornell, H. R. Wong, T. P. Shanley, and D. S. Wheeler, “The host response to sepsis and developmental impact,” Pediatrics, vol. 125, no. 5, pp. 1031–1041, 2010. View at: Publisher Site | Google Scholar
  9. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at: Publisher Site | Google Scholar
  10. J. C. Deng, G. Cheng, M. W. Newstead et al., “Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M,” The Journal of Clinical Investigation, vol. 116, no. 9, pp. 2532–2542, 2006. View at: Publisher Site | Google Scholar
  11. S. S. Santos, M. K. C. Brunialti, O. Rigato, F. R. MacHado, E. Silva, and R. Salomao, “Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes,” Shock, vol. 38, no. 1, pp. 18–23, 2012. View at: Publisher Site | Google Scholar
  12. M. T. Herrera, C. Toledo, F. Valladares et al., “Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model,” Intensive Care Medicine, vol. 29, no. 8, pp. 1345–1353, 2003. View at: Publisher Site | Google Scholar
  13. R. Campos, M. H. M. Shimizu, R. A. Volpini et al., “N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 302, no. 7, pp. L640–L650, 2012. View at: Publisher Site | Google Scholar
  14. M. C. J. Kneyber, R. P. Gazendam, H. W. M. Niessen et al., “Mechanical ventilation during experimental sepsis increases deposition of advanced glycation end products and myocardial inflammation,” Critical Care, vol. 13, no. 3, article R87, 2009. View at: Publisher Site | Google Scholar
  15. F. Lellouche, S. Dionne, S. Simard, J. Bussières, and F. Dagenais, “High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery,” Anesthesiology, vol. 116, no. 5, pp. 1072–1082, 2012. View at: Publisher Site | Google Scholar
  16. N. Nin, J. A. Lorente, P. Fernández-Segoviano, M. De Paula, A. Ferruelo, and A. Esteban, “High-tidal volume ventilation aggravates sepsis-induced multiorgan dysfunction in a dexamethasone-inhibitable manner,” Shock, vol. 31, no. 4, pp. 429–434, 2009. View at: Publisher Site | Google Scholar
  17. C. Menendez, L. Martinez-Caro, L. Moreno et al., “Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation,” Critical Care Medicine, vol. 41, no. 8, pp. E149–E155, 2013. View at: Publisher Site | Google Scholar
  18. W. A. Altemeier, G. Matute-Bello, C. W. Frevert et al., “Mechanical ventilation with moderate tidal volumes synergistically increases lung cytokine response to systemic endotoxin,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 287, no. 3, pp. L533–L542, 2004. View at: Publisher Site | Google Scholar
  19. M. Rincon and C. G. Irvin, “Role of IL-6 in asthma and other inflammatory pulmonary diseases,” International Journal of Biological Sciences, vol. 8, no. 9, pp. 1281–1290, 2012. View at: Publisher Site | Google Scholar
  20. A. A. Birukova, Y. Tian, A. Meliton, A. Leff, T. Wu, and K. G. Birukov, “Stimulation of Rho signaling by pathologic mechanical stretch is a “second hit” to Rho-independent lung injury induced by IL-6,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 302, no. 9, pp. L965–L975, 2012. View at: Publisher Site | Google Scholar
  21. T. C. Whitehead, H. Zhang, B. Mullen, and A. S. Slutsky, “Effect of mechanical ventilation on cytokine response to intratracheal lipopolysaccharide,” Anesthesiology, vol. 101, no. 1, pp. 52–58, 2004. View at: Publisher Site | Google Scholar
  22. M. Vaneker, F. J. Halbertsma, J. van Egmond et al., “Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings,” Anesthesiology, vol. 107, no. 3, pp. 419–426, 2007. View at: Publisher Site | Google Scholar
  23. R. G. Brower, M. A. Matthay, A. Morris, D. Schoenfeld, B. T. Thompson, and A. Wheeler, “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000. View at: Publisher Site | Google Scholar
  24. R. M. Determann, A. Royakkers, E. K. Wolthuis et al., “Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial,” Critical Care, vol. 14, no. 1, article 1, 2010. View at: Publisher Site | Google Scholar
  25. J. Villar, N. Cabrera, M. Casula et al., “Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model,” Intensive Care Medicine, vol. 36, no. 6, pp. 1049–1057, 2010. View at: Publisher Site | Google Scholar
  26. T. Nakamura, J. Malloy, L. McCaig et al., “Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines,” Journal of Applied Physiology, vol. 91, no. 2, pp. 811–820, 2001. View at: Google Scholar
  27. T. van der Poll and S. M. Opal, “Host-pathogen interactions in sepsis,” The Lancet Infectious Diseases, vol. 8, no. 1, pp. 32–43, 2008. View at: Publisher Site | Google Scholar
  28. N. V. Gorbunov, B. R. Garrison, D. P. McDaniel et al., “Adaptive redox response of mesenchymal stromal cells to stimulation with lipopolysaccharide inflammagen: mechanisms of remodeling of tissue barriers in sepsis,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 186795, 16 pages, 2013. View at: Publisher Site | Google Scholar
  29. H. D. Volk, P. Reinke, and W. D. Docke, “Clinical aspects: from systemic inflammation to ‘immunoparalysis’,” in Cd14 in the Inflammatory Response, vol. 74, pp. 162–177, 2000. View at: Google Scholar
  30. R. S. Hotchkiss and D. W. Nicholson, “Apoptosis and caspases regulate death and inflammation in sepsis,” Nature Reviews Immunology, vol. 6, no. 11, pp. 813–822, 2006. View at: Publisher Site | Google Scholar
  31. C. G. Davis, K. Chang, D. Osborne, A. H. Walton, W. M. Dunne, and J. T. Muenzer, “Increased susceptibility to Candida infection following cecal ligation and puncture,” Biochemical and Biophysical Research Communications, vol. 414, no. 1, pp. 37–43, 2011. View at: Publisher Site | Google Scholar
  32. C. F. Benjamim, C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel, “Septic mice are susceptible to pulmonary aspergillosis,” The American Journal of Pathology, vol. 163, no. 6, pp. 2605–2617, 2003. View at: Publisher Site | Google Scholar
  33. A. L. Coelho, M. A. Schaller, C. F. Benjamim, A. Z. Orlofsky, C. M. Hogaboam, and S. L. Kunkel, “The chemokine CCL6 promotes innate immunity via immune cell activation and recruitment,” Journal of Immunology, vol. 179, no. 8, pp. 5474–5482, 2007. View at: Publisher Site | Google Scholar
  34. C. F. Benjamim, S. K. Lundy, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel, “Reversal of long-term sepsis-induced immunosuppression by dendritic cells,” Blood, vol. 105, no. 9, pp. 3588–3595, 2005. View at: Publisher Site | Google Scholar
  35. M. T. Kuipers, H. Aslami, J. R. Janczy et al., “Ventilator-induced lung injury is mediated by the NLRP3 inflammasome,” Anesthesiology, vol. 116, no. 5, pp. 1104–1115, 2012. View at: Publisher Site | Google Scholar
  36. T. S. Cohen, G. G. Lawrence, A. Khasgiwala, and S. S. Margulies, “MAPk activation modulates permeability of isolated rat alveolar epithelial cell monolayers following cyclic stretch,” PLoS ONE, vol. 5, no. 4, Article ID e10385, 2010. View at: Publisher Site | Google Scholar
  37. J. Tang, J. J. Hu, C. H. Lu et al., “Propofol inhibits lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression through decreasing the generation of superoxide anion in cardiomyocytes,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 157376, 12 pages, 2014. View at: Publisher Site | Google Scholar
  38. M. Vaneker, L. A. Joosten, L. M. A. Heunks et al., “Low-tidal-volume mechanical ventilation induces a toll-like receptor 4-dependent inflammatory response in healthy mice,” Anesthesiology, vol. 109, no. 3, pp. 465–472, 2008. View at: Publisher Site | Google Scholar
  39. P. E. Charles and S. D. Barbar, “Toll-like receptors: a link between mechanical ventilation, innate immunity and lung injury?” Intensive Care Medicine, vol. 36, no. 6, pp. 909–911, 2010. View at: Publisher Site | Google Scholar
  40. J. Fan, Y. Li, Y. Vodovotz, T. R. Billiar, and M. A. Wilson, “Neutrophil NAD(P)H oxidase is required for hemorrhagic shock-enhanced TLR2 up-regulation in alveolar macrophages in response to LPS,” Shock, vol. 28, no. 2, pp. 213–218, 2007. View at: Publisher Site | Google Scholar

Copyright © 2015 Wei Xuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.